Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 31 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10265382

    Complexes of IL-15 and IL-15Ralpha and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  2. US 10266488

    4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  3. US 10265313

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  4. US 10266565

    Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  5. US 10258701

    Labeled evans blue dye derivative for in vivo serum albumin labeling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  6. US 10260054

    Engineered organophosphorus acid anhydrolases and methods of use thereof

    The United States of America as represented by the Secretary of the Army · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  7. US 10258686

    Materials and methods for respiratory disease control in canines

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEAS CONTROL AND PREVENTION · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  8. US 10258682

    Attenuated chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  9. US 10251912

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  10. US 10246463

    Hypoxia-inducible factor 1 (HIF-1) inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  11. US 10246505

    Chimeric antigen receptors to control HIV infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  12. US 10239830

    Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disorders

    The United States of America, as represented by the Secretary, Depart. of Health and Human Services · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  13. US 10233209

    Inhibitors of the farnesoid x receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  14. US 10227395

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  15. US 10220028

    Thio compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  16. US 10220103

    Magnetic microstructures for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  17. US 10213445

    Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  18. US 10215825

    Magnetic microstructures for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  19. US 10214732

    Lysin agent and method of use for diagnostic testing

    The United States of America, as represented by the Secretary of Homeland Security · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  20. US 10214726

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  21. US 10206995

    Live attenuated virus vaccines for la crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  22. US 10208035

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  23. US 10206957

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  24. US 10202367

    Heterocyclic compounds and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.